Last reviewed · How we verify
NCT05630625
The Drinking Dashboard Study
NA trial testing Drinking Dashboard in Alcohol Drinking in 169 participants. Completed in 9 April 2024.
9 April 2024
Quick facts
| Lead sponsor | University of Missouri-Columbia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 169 |
| Start date | 30 May 2023 |
| Primary completion | 9 April 2024 |
| Estimated completion | 9 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Drinking Dashboard
Conditions studied
- Alcohol Drinking — all drugs for Alcohol Drinking →
Sponsor
University of Missouri-Columbia
Who can join
Adults 18 to 30, any sex, with Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop and pilot test the efficacy of a "Drinking Dashboard" providing participants weekly feedback on the risk factors and consequences of blackout.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Drinking Dashboard for alcohol-induced blackout: A randomized pilot trial.
Miller MB, DiBello AM, Merrill JE, Shoemaker SD, et al · · 2025 · cited 1× · PMID 40445263 · DOI 10.1111/acer.70042 -
Health goals, sex, and college enrollment: Impacts on young adult response to digital alcohol intervention.
Miller MB, DiBello AM, Marut E, Bosworth KT, et al · · 2026 · PMID 41770167 · DOI 10.1037/adb0001126
Verify or expand the search:
- PubMed search for NCT05630625
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Drinking
Currently open trials in the same condition.
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
- NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
- NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting
Other University of Missouri-Columbia trials
Trials by the same sponsor.
- NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
- NCT07385105 — Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI) · NA · not yet recruiting
- NCT07067502 — Impact of Biphasic Cuirass Ventilation Compared to Non Invasive Ventilation in High Risk Extubations · NA · not yet recruiting
- NCT07424079 — Metacognitive Strategy Training Intervention for Transition-Age Youth With Cerebral Palsy · NA · not yet recruiting
- NCT07216196 — The Feasibility of a Remote Problem-Solving Intervention for Autistic Adolescents or Young Adults and a Caregiver · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05630625 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Missouri-Columbia
- Last refreshed: 27 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05630625.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing